MEDS DataMeds AI, Inc.
Nasdaq · SEC CIK 2030763 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 15 since 2025-03-25, latest 2026-06-25 16:59
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Patel Prashant | CEO, Dir | — | — |
| AJJARAPU SURENDRA K | Dir | — | — |
Transactions 17
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-25 16:59 | 2026-06-22 | MEDS | AJJARAPU SURENDRA K | Dir | X - OptEx | $0.005 | +100.0K | 257.6K | +63% | +$500 |
| D | 2026-06-25 16:57 | 2026-06-22 | MEDS | Patel Prashant | CEO, Dir | X - OptEx | $0.005 | +100.0K | 282.4K | +55% | +$500 |
| DA | 2026-06-25 16:15 | 2026-03-31 | MEDS | Patel Prashant | CEO, Dir | A - Grant | $0.2 | +5.00M | 9.12M | +121% | +$1.00M |
| DA | 2026-06-25 16:15 | 2026-03-31 | MEDS | AJJARAPU SURENDRA K | Dir | A - Grant | $0.2 | +5.00M | 7.88M | +173% | +$1.00M |
| D | 2026-04-23 20:55 | 2026-03-31 | MEDS | Patel Prashant | CEO, Dir | A - Grant | $0.2 | +5.00M | 9.12M | +121% | +$1.00M |
| D | 2026-04-23 20:52 | 2026-03-31 | MEDS | AJJARAPU SURENDRA K | Dir | A - Grant | $0.2 | +5.00M | 7.88M | +173% | +$1.00M |
| 2025-07-08 | 2025-07-02 | MEDS | PETERSON MICHAEL L | Dir | A - Grant | $0.9 | -200.0K | 200.0K | -50% | -$180.0K | |
| I | 2025-03-25 | 2025-03-21 | MEDS | Panchal Nikul | Chief Pharmacy Off | A - Grant | $0.00 | +90.0K | 90.0K | New | $0 |
| 2025-03-25 | 2025-03-21 | MEDS | Syed Sajid | Dir | A - Grant | $0.00 | +200.0K | 244.7K | +447% | $0 | |
| 2025-03-25 | 2025-03-21 | MEDS | Norton Brian | CEO | A - Grant | $0.00 | +9.00M | 9.04M | +20,125% | $0 | |
| 2025-03-25 | 2025-03-21 | MEDS | SHANAHAN REBECCA M | Dir | A - Grant | $0.00 | +200.0K | 244.7K | +447% | $0 | |
| 2025-03-25 | 2025-03-21 | MEDS | ANDERSON DONALD WILLIAM | Dir | A - Grant | $0.00 | +200.0K | 244.7K | +447% | $0 | |
| 2025-03-25 | 2025-03-21 | MEDS | Pirani Shafaat | Chief Clinical Off | A - Grant | $0.00 | +35.0K | 102.1K | +52% | $0 | |
| MI | 2025-03-25 | 2025-03-21 | MEDS | Patel Prashant | Chief Strategy Off, Dir | A - Grant | $0.00 | +2.20M | 1.50M | New | $0 |
| 2025-03-25 | 2025-03-21 | MEDS | Patel Prashant | Chief Strategy Off, Dir | A - Grant | $0.00 | +1.88M | 4.12M | +84% | $0 | |
| 2025-03-25 | 2025-03-21 | MEDS | AJJARAPU SURENDRA K | Dir | A - Grant | $0.00 | +2.88M | 1.82M | New | $0 | |
| MI | 2025-03-25 | 2025-03-21 | MEDS | AJJARAPU SURENDRA K | Dir | A - Grant | $0.00 | +1.20M | 4.46M | +37% | $0 |
Purchase Sale Sale after option exercise All abbreviations